Diagnostic pathology of diffuse lung disease in children

Pediatric, Allergy, Immunology, and Pulmonology

Volumn 23, Issue 1, 2010, Pages 69-85

  Dishop, Megan K ^a  

^a CHILDREN S HOSPITAL COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABC TRANSPORTER; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR RECEPTOR; SURFACTANT PROTEIN B; SURFACTANT PROTEIN C;

ACINAR DYSGENESIS; ALLERGIC PNEUMONITIS; ALVEOLAR CAPILLARY DYSPLASIA; ASTHMA; BRONCHIOLITIS; CHILDHOOD DISEASE; CONGENITAL ALVEOLAR DYSPLASIA; CONGENITAL HEART DISEASE; CONGENITAL HYPOTHYROIDISM; CYSTIC FIBROSIS; DERMATOMYOSITIS; DIFFUSE LUNG DISEASE; DOWN SYNDROME; FIBROSING ALVEOLITIS; GENE DELETION; GENE MUTATION; GENETIC ASSOCIATION; GLYCOGEN STORAGE DISEASE; GRAFT VERSUS HOST REACTION; GRANULOMATOUS PNEUMONITIS; HISTIOCYTOSIS X; HISTOPATHOLOGY; HUMAN; LEUKEMIA; LOEFFLER PNEUMONIA; LUNG BIOPSY; LUNG DEVELOPMENT; LUNG DISEASE; LUNG DYSPLASIA; LUNG GRAFT REJECTION; LUNG HEMOSIDEROSIS; LUNG HYPOPLASIA; LYMPHANGIOLEIOMYOMATOSIS; LYMPHANGIOMATOSIS; LYMPHOMA; MECONIUM ASPIRATION; MUCOPOLYSACCHARIDOSIS; NEUROENDOCRINE CELL HYPERPLASIA OF INFANCY; NIEMANN PICK DISEASE; NONSPECIFIC INTERSTITIAL PNEUMONIA; OPPORTUNISTIC INFECTION; PATHOGENESIS; PNEUMONIA; PRIORITY JOURNAL; PULMONARY INTERSTITIAL GLYCOGENOSIS; PULMONARY VASCULAR DISEASE; REVIEW;

EID: 78049358150     PISSN: 2151321X     EISSN: 21513228     Source Type: Journal    
DOI: 10.1089/ped.2010.0007     Document Type: Review

References (99)

1. Langston C, Patterson K, Dishop MK, Askin F, Baker P, Chou P, Cool C, Coventry S, Cutz E, Davis M, Deutsch G, Galambos C, Pugh J, Wert S, White F; chILD Pathology Co-operative Group:, A protocol for the handling of tissue obtained by operative lung biopsy: recommendations of the chILD pathology co-operative group, Pediatr Dev Pathol 2006; 9: 173-180.
2. Gianoulis M, Chan N, Wright JL, Infl ation of lung biopsies for frozen section, Mod Pathol 1988; 1: 357-358.
3. Deutsch GH, Young LR, Deterding RR, Fan LL, Dell SD, Bean JA, Brody AS, Nogee LM, Trapnell BC, Langston C, Albright EA, Askin FB, Baker P, Chou PM, Cool CM, Coventry SC, Cutz E, Davis MM, Dishop MK, Galambos C, Patterson K, Travis WD, Wert SE, White FV; Pathology Cooperative Group; ChILD Research Co-operative, Diffuse lung disease in young children: application of a novel classifi cation scheme, Am J Respir Crit Care Med 2007; 176: 1120-1128.
4. Langston C, Dishop MK, Diffuse lung disease in infancy: a proposed classifi cation applied to 259 diagnostic biopsies, Pediatr Dev Pathol 2009; 12: 421-437.
5. Fan LL, Kozinetz CA, Deterding RR, Brugman SM, Evaluation of a diagnostic approach to pediatric interstitial lung disease, Pediatrics 1998; 101: 82-85.
6. Howenstine MS, Eigen H, Current concepts on interstitial lung disease in children, Curr Opin Pediatr 1999; 11: 200-204.
7. Coren ME, Nicholson AG, Goldstraw P, Rosenthal M, Bush A, Open lung biopsy for diffuse interstitial lung disease in children. Eur Respir J 1999; 14: 817-821.
8. Langston C, Fan LL, The spectrum of interstitial lung disease in childhood, Pediatr Pulmonol 2001; (Suppl 23): 70-71. (Pubitemid 33021805)
9. Fan LL, Langston C, Pediatric interstitial lung disease: children are not small adults, Am J Respir Crit Care Med 2002; 165: 1466-1467.
10. Clement A, Henrion-Caude A, Fauroux B, The pathogenesis of interstitial lung diseases in children, Paediatr Respir Rev 2004; 5: 94-97. (Pubitemid 38701806)
11. Hilman BC, Amaro-Galvez R, Diagnosis of interstitial lung disease in children, Paediatr Respir Rev 2004; 5: 101-107.
12. Fan LL, Deterding RR, Langston C, Pediatric interstitial lung disease revisited, Pediatr Pulmonol 2004; 38: 369-378.
13. Clement A; ERS Task Force, Task force on chronic interstitial lung disease in immunocompetent children, Eur Respir J 2004; 24: 686-697. (Pubitemid 39406144)
14. Nogee LM, de Mello DE, Dehner LP, Colten HR, Brief report: defi ciency of pulmonary surfactant protein B in congenital alveolar proteinosis, N Engl J Med 1993; 328: 406-410.
15. Nogee LM, Garnier G, Dietz HC, Singer L, Murphy AM, deMello DE, Colten HR, A mutation in the surfactant protein B gene responsible for fatal neonatal respiratory disease in multiple kindreds. J Clin Invest 1994; 93: 1860-1863
16. deMello DE, Nogee LM, Heyman S, Krous HF, Hussain M, Merritt TA, Hsueh W, Haas JE, Heidelberger K, Schumacher R, Molecular and phenotypic variability in the congenital alveolar proteinosis syndrome associated with inherited surfactant protein B defi ciency, J Pediatr 1994; 125: 43-50.
17. Nogee LM, Dunbar AE 3rd, Wert SE, Askin F, Hamvas A, Whitsett JA, A mutation in the surfactant protein C gene associated with familial interstitial lung disease, N Engl J Med 2001; 344: 573-579.
18. Tredano M, Griese M, Brasch F, Schumacher S, de Blic J, Marque S, Houdayer C, Elion J, Couderc R, Bahuau M, Mutation of SFTPC in infantile pulmonary alveolar proteinosis with or without fi brosing lung disease, Am J Med Genet A 2004; 126A: 18-26.
19. Lawson WE, Grant SW, Ambrosini V, Womble KE, Dawson EP, Lane KB, Markin C, Renzoni E, Lympany P, Thomas AQ, Roldan J, Scott TA, Blackwell TS, Phillips JA 3rd, Loyd JE, du Bois RM, Genetic mutations in surfactant protein C are a rare cause of sporadic cases of IPF, Thorax 2004; 59: 977-980.
20. Katzenstein AL, Gordon LP, Oliphant M, Swender PT, Chronic pneumonitis of infancy. A unique form of interstitial lung disease occurring in early childhood, Am J Surg Pathol 1995; 19: 439-447.
21. Fisher M, Roggli V, Merten D, Mulvihill D, Spock A, Coexisting endogenous lipoid pneumonia, cholesterol granulomas, and pulmonary alveolar proteinosis in a pediatric population: a clinical, radiographic, and pathologic correlation, Pediatr Pathol 1992; 12: 365-383.
22. Chibbar R, Shih F, Baga M, Torlakovic E, Ramlall K, Skomro R, Cockcroft DW, Lemire EG, Nonspecifi c interstitial pneumonia and usual interstitial pneumonia with mutation in surfactant protein C in familial pulmonary fi brosis, Mod Pathol 2004; 17: 973-980.
23. Shulenin S, Nogee LM, Annilo T, Wert SE, Whitsett JA, Dean M, ABCA3 gene mutations in newborns with fatal surfactant defi-ciency, N Engl J Med 2004; 350: 1296-1303.
24. Doan ML, Guillerman RP, Dishop MK, Nogee LM, Langston C, Mallory GB, Sockrider MM, Fan LL, Clinical, radiological and pathological features of ABCA3 mutations in children, Thorax 2008; 63: 366-373.
25. Bullard JE, Wert SE, Whitsett JA, Dean M, Nogee LM, ABCA3 mutations associated with pediatric interstitial lung disease, Am J Respir Crit Care Med 2005; 172: 1026-1031.
26. Edwards V, Cutz E, Viero S, Moore AM, Nogee L, Ultrastructure of lamellar bodies in congenital surfactant defi ciency, Ultrastruct Pathol 2005; 29: 503-509
27. deMello DE, Heyman S, Phelps DS, Hamvas A, Nogee L, Cole S, Colten HR, Ultrastructure of lung in surfactant protein B defi-ciency, Am J Respir Cell Mol Biol 1994; 11: 230-239.
28. Tryka AF, Wert SE, Mazursky JE, Arrington RW, Nogee LM, Absence of lamellar bodies with accumulation of dense bodies characterizes a novel form of congenital surfactant defect, Pediatr Dev Pathol 2000; 3: 335-345.
29. Cutz E, Wert SE, Nogee LM, Moore AM, Defi ciency of lamellar bodies in alveolar type II cells associated with fatal respiratory disease in a full-term infant, Am J Respir Crit Care Med 2000; 161: 608-614.
30. Martinez-Moczygemba M, Doan ML, Elidemir O, Fan LL, Cheung SW, Lei JT, Moore JP, Tavana G, Lewis LR, Zhu Y, Muzny DM, Gibbs RA, Huston DP, Pulmonary alveolar proteinosis caused by deletion of the GM-CSFRalpha gene in the X chromosome pseudoautosomal region 1, J Exp Med 2008; 205: 2711-2716.
31. Suzuki T, Sakagami T, Rubin BK, Nogee LM, Wood RE, Zimmerman SL, Smolarek T, Dishop MK, Wert SE, Whitsett JA, Grabowski G, Carey BC, Stevens C, van der Loo JC, Trapnell BC, Familial pulmonary alveolar proteinosis caused by mutations in CSF2RA, J Exp Med 2008; 205: 2703-2710.
32. Maquet E, Costagliola S, Parma J, Christophe-Hobertus C, Oligny LL, Fournet JC, Robitaille Y, Vuissoz JM, Payot A, Laberge S, Vassart G, Van Vliet G, Deladoëy J, Lethal respiratory failure and mild primary hypothyroidism in a term girl with a de novo heterozygous mutation in the TITF1/NKX2.1 gene, J Clin Endocrinol Metab 2009; 94: 197-203.
33. Carré A, Szinnai G, Castanet M, Sura-Trueba S, Tron E, Broutin-L'Hermite I, Barat P, Goizet C, Lacombe D, Moutard ML, Raybaud C, Raynaud-Ravni C, Romana S, Ythier H, Léger J, Polak M, Five new TTF1/NKX2.1 mutations in brain-lung-thyroid syndrome: rescue by PAX8 synergism in one case, Hum Mol Genet 2009; 18: 2266-2276.
34. Bedrossian CW, Luna MA, Conklin RH, Miller WC, Alveolar proteinosis as a consequence of immunosuppression. A hypothesis based on clinical and pathologic observations, Hum Pathol 1980; 11: 527-535.
35. Nachajon RV, Rutstein RM, Rudy BJ, Collins MH, Pulmonary alveolar proteinosis in an HIV-infected child, Pediatr Pulmonol 1997; 24: 292-295.
36. Samuels MP, Warner JO, Pulmonary alveolar lipoproteinosis complicating juvenile dermatomyositis, Thorax 1988; 43: 939-940.
37. Parto K, Svedström E, Majurin ML, Härkönen R, Simell O, Pulmonary manifestations in lysinuric protein intolerance, Chest 1993; 104: 1176-1182. (Pubitemid 23306073)
38. Janney CG, Askin FB, Kuhn C 3rd. Congenital alveolar capillary dysplasia\an unusual cause of respiratory distress in the newborn. Am J Clin Pathol 1981; 76: 722-727.
39. Wagenvoort CA, Misalignment of lung vessels: a syndrome causing persistent neonatal pulmonary hypertension, Hum Pathol 1986; 17: 727-730.
40. Langston C, Misalignment of pulmonary veins and alveolar capillary dysplasia, Pediatr Pathol 1991; 11: 163-170.
41. Haraida S, Lochbühler H, Heger A, Nerlich A, Diebold J, Wiest I, Müller-Höcker J, Löhrs U, Congenital alveolar capillary dysplasia: rare cause of persistent pulmonary hypertension, Pediatr Pathol Lab Med 1997; 17: 959-975.
42. Boggs S, Harris MC, Hoffman DJ, Goel R, McDonald-McGinn D, Langston C, Zackai E, Ruchelli E, Misalignment of pulmonary veins with alveolar capillary dysplasia: affected siblings and variable phenotypic expression, J Pediatr 1994; 124: 125-128.
43. Gutierrez C, Rodriguez A, Palenzuela S, Forteza C, Rossello JL, Congenital misalignment of pulmonary veins with alveolar capillary dysplasia causing persistent neonatal pulmonary hypertension: report of two affected siblings, Pediatr Dev Pathol 2000; 3: 271-276.
44. Garola RE, Thibeault DW, Alveolar capillary dysplasia, with and without misalignment of pulmonary veins: an association of congenital anomalies, Am J Perinatol 1998; 15: 103-107.
45. Sen P, Thakur N, Stockton DW, Langston C, Bejjani BA, Expanding the phenotype of alveolar capillary dysplasia (ACD), J Pediatr 2004; 145: 646-651.
46. Eulmesekian P, Cutz E, Parvez B, Bohn D, Adatia I, Alveolar capillary dysplasia: a six-year single center experience, J Perinat Med 2005; 33: 347-352.
47. Licht C, Schickendantz S, Sreeram N, Arnold G, Rossi R, Vierzig A, Mennicken U, Roth B, Prolonged survival in alveolar capillary dysplasia syndrome, Eur J Pediatr 2004; 163: 181-182.
48. Al-Hathlol K, Phillips S, MK Seshia, Casiro O Alvaro RE Rigatto H, Alveolar capillary dysplasia. Report of a case of prolonged life without extracorporeal membrane oxygenation (ECMO) and review of the literature, Early Hum Dev 2000; 57: 85-94.
49. Abdallah HI, Karmazin N, Marks LA, Late presentation of misalignment of lung vessels with alveolar capillary dysplasia, Crit Care Med 1993; 21: 628-630.
50. Stankiewicz P, Sen P, Bhatt SS, Storer M, Xia Z, Bejjani BA, Ou Z, Wiszniewska J, Driscoll DJ, Maisenbacher MK, Bolivar J, Bauer M, Zackai EH, McDonald-McGinn D, Nowaczyk MM, Murray M, Hustead V, Mascotti K, Schultz R, Hallam L, McRae D, Nicholson AG, Newbury R, Durham-O'Donnell J, Knight G, Kini U, Shaikh TH, Martin V, Tyreman M, Simonic I, Willatt L, Paterson J, Mehta S, Rajan D, Fitzgerald T, Gribble S, Prigmore E, Patel A, Shaffer LG, Carter NP, Cheung SW, Langston C, Shaw-Smith C, Genomic and genic deletions of the FOX gene cluster on 16q24.1 and inactivating mutations of FOXF1 cause alveolar capillary dysplasia and other malformations, Am J Hum Genet 2009; 84: 780-791.
51. Greenough A, Factors adversely affecting lung growth, Paediatr Respir Rev 2000; 1: 314-320.
52. Margraf LR, Tomashefski JF Jr, Bruce MC, Dahms BB, Morphometric analysis of the lung in bronchopulmonary dysplasia. Am Rev Respir Dis 1991; 143: 391-400.
53. O'Brodovich HM, Mellins RB, Bronchopulmonary dysplasia. Unresolved neonatal acute lung injury, Am Rev Respir Dis 1985; 132: 694-709.
54. Bonikos DS, Bensch KG, Northway WH Jr, Edwards DK, Bronchopulmonary dysplasia: the pulmonary pathologic sequel of necrotizing bronchiolitis and pulmonary fi brosis, Hum Pathol 1976; 7: 643-666.
55. Stocker JT, Pathologic features of long-standing "healed" bronchopulmonary dysplasia: a study of 28 3-to 40-month-old infants, Hum Pathol 1986; 17: 943-961.
56. Husain AN, Siddiqui NH, Stocker JT, Pathology of arrested acinar development in postsurfactant bronchopulmonary dysplasia. Hum Pathol 1998; 29: 710-717.
57. Coalson JJ, Pathology of new bronchopulmonary dysplasia, Semin Neonatol 2003; 8: 73-81.
58. Thurlbeck WM, Kida K, Langston C, Cowan MJ, Kitterman JA, Tooley W, Bryan H, Postnatal lung growth after repair of diaphragmatic hernia, Thorax 1979; 34: 338-343.
59. Cooney TP, Thurlbeck WM, Pulmonary hypoplasia in Down's syndrome, N Engl J Med 1982; 307: 1170-1173.
60. Cooney TP, Wentworth PJ, Thurlbeck WM, Diminished radial count is found only postnatally in Down's syndrome, Pediatr Pulmonol 1988; 5: 204-209.
61. Schloo BL, Vawter GF, Reid LM, Down syndrome: patterns of disturbed lung growth, Hum Pathol 1991; 22: 919-923.
62. Gonzalez OR, Gomez IG, Recalde AL, Landing BH, Postnatal development of the cystic lung lesion of Down syndrome: suggestion that the cause is reduced formation of peripheral air spaces, Pediatr Pathol 1991; 11: 623-633.
63. Tyrrell VJ, Asher MI, Chan Y, Subpleural lung cysts in Down's syndrome, Pediatr Pulmonol 1999; 28: 145-148.
64. Schroeder SA, Shannon DC, Mark EJ, Cellular interstitial pneumonitis in infants. A clinicopathologic study, Chest 1992; 101: 1065-1069.
65. Canakis AM, Cutz E, Manson D, O'Brodovich H, Pulmonary interstitial glycogenosis: a new variant of neonatal interstitial lung disease, Am J Respir Crit Care Med 2002; 165: 1557-1565.
66. Smets K, Dhaene K, Schelstraete P, Meersschaut V, Vanhaesebrouck P, Neonatal pulmonary interstitial glycogen accumulation disorder, Eur J Pediatr 2004; 163: 408-409.
67. Onland W, Molenaar JJ, Leguit RJ, van Nierop JC, Noorduyn LA, van Rijn RR, Geukers VG, Pulmonary interstitial glycogenosis in identical twins, Pediatr Pulmonol 2005; 40: 362-366.
68. Deutsch GH, Young LR, Histologic resolution of pulmonary interstitial glycogenosis, Pediatr Dev Pathol 2009; 12: 475-480.
69. Deterding RR, Fan LL, Morton R, Hay TC, Langston C, Persistent tachypnea of infancy (PTI)\a new entity, Pediatr Pulmonol 2001; (Suppl 23): 72-73.
70. Deterding RR, Pye C, Fan LL, Langston C, Persistent tachypnea of infancy is associated with neuroendocrine cell hyperplasia, Pediatr Pulmonol 2005; 40: 157-165.
71. Brody AS, Guillerman RP, Hay TC, Wagner BD, Young LR, Deutsch GH, Fan LL, Deterding RR, Neuroendocrine cell hyperplasia of infancy: diagnosis with high-resolution CT, AJR Am J Roentgenol 2010; 194: 238-244.
72. Cutz E, Yeger H, Pan J, Pulmonary neuroendocrine cell system in pediatric lung disease-recent advances, Pediatr Dev Pathol 2007; 10: 419-435.
73. Johnson DE, Anderson WR, Burke BA, Pulmonary neuroendocrine cells in pediatric lung disease: alterations in airway structure in infants with bronchopulmonary dysplasia, Anat Rec 1993; 236: 115-119, 172
74. Johnson DE, Wobken JD, Landrum BG, Changes in bombesin, calcitonin, and serotonin immunoreactive pulmonary neuroendocrine cells in cystic fi brosis and after prolonged mechanical ventilation, Am Rev Respir Dis 1988; 137: 123-131.
75. Asabe K, Tsuji K, Handa N, Kajiwara M, Suita S, Immunohistochemical distribution of bombesin-positive pulmonary neuroendocrine cells in a congenital diaphragmatic hernia, Surg Today 1999; 29: 407-412.
76. Alshehri M, Cutz E, Banzhoff A, Canny G, Hyperplasia of pulmonary neuroendocrine cells in a case of childhood pulmonary emphysema, Chest 1997; 112: 553-556.
77. Perrin DG, McDonald TJ, Cutz E, Hyperplasia of bombesin-immunoreactive pulmonary neuroendocrine cells and neuroepithelial bodies in sudden infant death syndrome, Pediatr Pathol 1991; 11: 431-447.
78. Gillan JE, Cutz E, Abnormal pulmonary bombesin immunoreactive cells in Wilson-Mikity syndrome (pulmonary dysmaturity) and bronchopulmonary dysplasia, Pediatr Pathol 1993; 13: 165-180.
79. Hammond S, Chenever E, Durbin JE, Respiratory virus infection in infants and children, Pediatr Dev Pathol 2007; 10: 172-180.
80. Moonnumakal SP, Fan LL, Bronchiolitis obliterans in children, Curr Opin Pediatr 2008; 20: 272-278.
81. Swaminathan S, Quinn J, Stabile MW, Bader D, Platzker AC, Keens TG, Long-term pulmonary sequelae of meconium aspiration syndrome, J Pediatr 1989; 114: 356-361.
82. Nathan L, Leveno KJ, Carmody TJ 3rd, Kelly MA, Sherman ML, Meconium: a 1990s perspective on an old obstetric hazard, Obstet Gynecol 1994; 83: 329-332.
83. Gadol CL, Joshi VV, Lee EY, Bronchiolar obstruction associated with repeated aspiration of vegetable material in two children with cerebral palsy, Pediatr Pulmonol 1987; 3: 437-439.
84. Fan LL, Hypersensitivity pneumonitis in children, Curr Opin Pediatr 2002; 14: 323-326.
85. Oermann CM, Panesar KS, Langston C, Larsen GL, Menendez AA, Schofield DE, Cosio C, Fan LL, Pulmonary infi ltrates with eosinophilia syndromes in children, J Pediatr 2000; 136: 351-358.
86. Katzenstein AL, Fiorelli RF, Nonspecifi c interstitial pneumonia/fi brosis. Histologic features and clinical signifi cance, Am J Surg Pathol 1994; 18: 136-147.
87. Yousem SA, Colby TV, Carrington CB, Follicular bronchitis/bronchiolitis, Hum Pathol 1985; 16: 700-706.
88. Athreya BH, Doughty RA, Bookspan M, Schumacher HR, Sewell EM, Chatten J, Pulmonary manifestations of juvenile rheumatoid arthritis. A report of eight cases and review, Clin Chest Med 1980; 1: 361-374.
89. Lovell D, Lindsley C, Langston C, Lymphoid interstitial pneumonia in juvenile rheumatoid arthritis, J Pediatr 1984; 105: 947-950.
90. Grieco MH, Chinoy-Acharya P, Lymphocytic interstitial pneumonia associated with the acquired immune defi ciency syndrome. Am Rev Respir Dis 1985; 131: 952-955.
91. Joshi VV, Oleske JM, Minnefor AB, Saad S, Klein KM, Singh R, Zabala M, Dadzie C, Simpser M, Rapkin RH, Pathologic pulmonary fi ndings in children with the acquired immunodefi ciency syndrome: a study of ten cases, Hum Pathol 1985; 16: 241-246.
92. Kinane BT, Mansell AL, Zwerdling RG, Lapey A, Shannon DC, Follicular bronchitis in the pediatric population, Chest 1993; 104: 1183-1186.
93. Sondheimer HM, Lung MC, Brugman SM, Ikle DN, Fan LL, White CW, Pulmonary vascular disorders masquerading as interstitial lung disease, Pediatr Pulmonol 1995; 20: 284-288.
94. Cool CD, Deutsch G, Pulmonary arterial hypertension from a pediatric perspective, Pediatr Dev Pathol 2008; 11: 169-177.
95. Rabinovitch M, Haworth SG, Castaneda AR, Nadas AS, Reid LM, Lung biopsy in congenital heart disease: a morphometric approach to pulmonary vascular disease, Circulation 1978; 58: 1107-1122.
96. Haworth SG, Pulmonary vascular disease in different types of congenital heart disease. Implications for interpretation of lung biopsy fi ndings in early childhood, Br Heart J 1984; 52: 557-571.
97. Faul JL, Berry GJ, Colby TV, Ruoss SJ, Walter MB, Rosen GD, Raffi n TA, Thoracic lymphangiomas, lymphangiectasis, lymphangiomatosis, and lymphatic dysplasia syndrome, Am J Respir Crit Care Med 2000; 161: 1037-1046.
98. Susarla SC, Fan LL, Diffuse alveolar hemorrhage syndromes in children, Curr Opin Pediatr 2007; 19: 314-320.
99. Fullmer JJ, Langston C, Dishop MK, Fan LL, Pulmonary capillaritis in children: a review of eight cases with comparison to other alveolar hemorrhage syndromes, J Pediatr 2005; 146: 376-381